News

Katherine Baker, MD, and colleagues investigated how the Enhancing Oncology Model captures the performance risk and treatment costs within a disease.

On September 15, 2023, the FDA approved momelotinib for the treatment of adult patients with myelofibrosis and anemia.

Puneeth Indurlal, MD, MS, The US Oncology Network, McKesson, The Woodlands, Texas, and colleagues investigated the impact of different dosing approaches of lenalidomide on the total cost of care for patients in The US Oncology Network.

Dr Houston and colleagues assessed the care capacity and improvement strategies of pediatric institutions that care for children with cancer.

Research presented at the 2023 ASCO Quality Care Symposium revealed unequal impacts on patients from recent policy changes preventing home delivery of prescription oncology medication.

In this study, Gunjan Sharma, MS, and colleagues examine the impact of end-of-life costs on patients and caregivers, and how it influences value-based care models for physicians.

An innovative virtual consult pilot launched by Kaiser Permanente saw success in bridging the gap between oncologists and cancer subspecialists within the organization.

In this study, high alarm rates from ambulatory chemotherapy pumps that caused disruptions in dose deliveries were analyzed and a quality improvement program was initiated to address concerns over safe delivery of chemotherapy to patients.

Researchers examined the impact of the shift toward oral anti-cancer drugs and the consequent rise in costs within the Oncology Care Model. The abstract was presented at the 2023 ASCO Quality Care Symposium in Boston, Massachusetts.

A recent study by Bruno Scodari, MD, and colleagues characterized oncologists who travel to rural areas to provide more access to cancer care and examined the effectiveness of this outreach method in reducing travel burden on patients.